Patients with the same mutations in DUOX2, TG, or TPO demonstrate a broad spectrum of clinical phenotypes ranging from mild to severe CH or from transient to permanent hypothyroidism [12, 14, 18–22]. This evidence concerns the gene DUOX2 and cyclic hematopoiesis.